978 related articles for article (PubMed ID: 2997432)
1. Receptors for opioid peptides in the guinea-pig ileum.
Takemori AE; Portoghese PS
J Pharmacol Exp Ther; 1985 Nov; 235(2):389-92. PubMed ID: 2997432
[TBL] [Abstract][Full Text] [Related]
2. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
[TBL] [Abstract][Full Text] [Related]
3. Opioid agonist affinity in the guinea-pig ileum and mouse vas deferens.
Porreca F; LoPresti D; Ward SJ
Eur J Pharmacol; 1990 Apr; 179(1-2):129-39. PubMed ID: 2163849
[TBL] [Abstract][Full Text] [Related]
4. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
Suh HH; Tseng LF
J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
[TBL] [Abstract][Full Text] [Related]
5. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.
Tortella FC; Robles L; Mosberg HI
J Pharmacol Exp Ther; 1987 Feb; 240(2):571-7. PubMed ID: 3027318
[TBL] [Abstract][Full Text] [Related]
6. [Cys(O2NH2)2]enkephalin analogues and dalargin: selectivity for delta-opioid receptors.
Pencheva N; Bocheva A; Dimitrov E; Ivancheva C; Radomirov R
Eur J Pharmacol; 1996 May; 304(1-3):99-108. PubMed ID: 8813590
[TBL] [Abstract][Full Text] [Related]
7. Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of beta-funaltrexamine.
Hayes AG; Sheehan MJ; Tyers MB
Br J Pharmacol; 1985 Dec; 86(4):899-904. PubMed ID: 3000501
[TBL] [Abstract][Full Text] [Related]
8. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
9. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
Locke KW; Holtzman SG
J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
[TBL] [Abstract][Full Text] [Related]
10. Opioid antagonist properties of the highly delta-receptor-selective BOC-Tyr-Pro-Gly-Phe-Leu-Thr (OtBu) peptide and of its Phe1 and Mel1 analogues.
Rónai AZ; Magyar A; Orosz G; Borsodi A; Benyhe S; Tóth G; Makó E; Kátay E; Babka E; Medzihradszky K
Arch Int Pharmacodyn Ther; 1995; 330(3):361-9. PubMed ID: 8836454
[TBL] [Abstract][Full Text] [Related]
11. A novel phencyclidine analog interacts selectively with mu opioid receptors.
Itzhak Y; Simon EJ
J Pharmacol Exp Ther; 1984 Aug; 230(2):383-6. PubMed ID: 6086884
[TBL] [Abstract][Full Text] [Related]
12. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
Werling LL; Zarr GD; Brown SR; Cox BM
J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494
[TBL] [Abstract][Full Text] [Related]
13. Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217.
Cohen ML; Shuman RT; Osborne JJ; Gesellchen PD
J Pharmacol Exp Ther; 1986 Sep; 238(3):769-72. PubMed ID: 2875170
[TBL] [Abstract][Full Text] [Related]
14. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
Jiang Q; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319
[TBL] [Abstract][Full Text] [Related]
15. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
Ward SJ; Takemori AE
J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
[TBL] [Abstract][Full Text] [Related]
16. Two new opioid delta-receptor ligands: a highly selective agonist and a potent selective antagonist in in vitro isolated preparations.
Ueki M; Aoki K; Kajiwara M; Shinozaki K; Inoue H; Oka T
Jpn J Pharmacol; 1984 Dec; 36(4):485-9. PubMed ID: 6098760
[TBL] [Abstract][Full Text] [Related]
17. Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists.
Takemori AE; Portoghese PS
Eur J Pharmacol; 1984 Sep; 104(1-2):101-4. PubMed ID: 6094203
[TBL] [Abstract][Full Text] [Related]
18. Characterization of kappa and delta opioid receptors in isolated organs by using type/subtype selective agonists and antagonists.
Makó E; Rónai AZ
Med Sci Monit; 2001; 7(3):350-6. PubMed ID: 11386008
[TBL] [Abstract][Full Text] [Related]
19. Deltakephalin, Tyr-D-Thr-Gly-Phe-Leu-Thr: a new highly potent and fully specific agonist for opiate delta-receptors.
Zajac JM; Gacel G; Petit F; Dodey P; Rossignol P; Roques BP
Biochem Biophys Res Commun; 1983 Mar; 111(2):390-7. PubMed ID: 6301470
[TBL] [Abstract][Full Text] [Related]
20. beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence.
Rothman RB; Long JB; Bykov V; Jacobson AE; Rice KC; Holaday JW
J Pharmacol Exp Ther; 1988 Nov; 247(2):405-16. PubMed ID: 2846819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
